When former Nebraska Sen. Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by Revolution Medicines is giving him precious more ...

Serious cases of pancreatitis (inflammation of the pancreas) have been reported with GLP-1 use, but its overall occurrence is considered rare. Large-scale research shows GLP-1s, including Ozempic and ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...

Pancreatic cancer is one of the deadliest cancers. It killed nearly 52,000 Americans last year, many within a year of diagnosis. Now, there are some new experimental medicines with the potential to ...

SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates could substantially improve for pancreatic cancer, one of the most stubbornly ...

After decades of struggling to find a way to treat pancreatic cancer, researchers have developed several promising new drugs that could offer rare hope to patients given this particularly deadly ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A rare inherited disorder prevents the body from clearing dietary fats from the bloodstream, ...

CHICAGO (WLS) -- A drug trial at Northwestern Medicine offers hopeful results to those with pancreatic cancer. GI Oncologist Dr. Deva Mahalingam is the lead author for research published on Tuesday.

Pancreatic cancer is one of the most challenging diseases to treat, and while survival rates have improved since the 1970s, they have plateaued in recent years. But two promising drugs in the pipeline ...

New data finds an experimental cancer treatment is showing major promise. Our team spoke with the first person to receive a personalized mRNA vaccine for pancreatic cancer at Memorial Sloan Kettering, ...

Donna Gustafson had a harder time than usual shaking off the jet lag from her 22-hour journey from Florida to Australia. Two days into her trip, her skin took on the yellow hue of jaundice. Gustafson, ...